Ahmed Muhammad Tambra Riaz focuses his practice in intellectual property providing counsel and support in connection with patent and trademark enforcement and defense. His practice includes Hatch-Waxman Paragraph IV disputes and patent troll issues.
Ahmed’s transactional practice focuses on negotiating and drafting licensing, commercial supply, clinical trial, and distribution agreements. Ahmed has also counseled start-up and early stage companies looking to grow their business while avoiding costly litigation.
A curious and highly analytical attorney with substantive in-house experience, Ahmed is known for his ability to understand complex technologies and develop effective litigation strategies in view of his clients’ business realities.
Prior to joining Schiff Hardin, Ahmed was in-house counsel for a publicly traded medical device company. In this role, he helped to develop, protect and capitalize on the strategic development of an international intellectual property portfolio and managed multiple litigations.
Ahmed also gained extensive experience negotiating and preparing licensing, commercial supply and co-promotion agreements, and importantly gained first-hand knowledge of the business realities that inform business and legal decisions.
- Successfully represented Fresenius Kabi USA, LLC in obtaining a rare preliminary injunction in federal district court. The injunction barred our client’s competitor from launching a generic version of its patented formulation of levothyroxine, an injectable thyroid hormone. The District Court for the District of New Jersey granted the injunction on the basis that our client was likely to win its patent lawsuit against its competitor.
- Managed litigation strategy for plaintiff in a declaratory judgment action seeking a preliminary injunction as in-house counsel.
- Managed inter partes review strategies as in-house counsel at medical device company.
As in-house counsel, Ahmed’s representative experience included:
- Negotiating and drafting U.S. promotion agreement out licensing drug product for marketing in South Korea on an exclusive basis.
- Negotiating and drafting license agreement out-licensing drug technology to develop over the counter drug product on exclusive basis for North America.
- Negotiating and drafting License, Supply, and Distribution Agreement with generic company out licensing device technology for a drug-device combination product in the United States.
- Temple University Beasley School of Law, J.D., 2008
- Hunter College, B.A., Economics, 2004
- New York
- New Jersey
- U.S. Court of Appeals for the Federal Circuit
- U.S. District Court for the District of New Jersey
- American Bar Association, Intellectual Property Law Section
- American Intellectual Property Law Association
Rate : $$$